Corticosteroid-associated osteonecrosis: A rare, but serious, complication in uveitis

Ocular Immunology and Inflammation

Volumn 21, Issue 2, 2013, Pages 102-107

  Smith, Wendy M ^a   Larson, Theresa A ^a   Meleth, A Dhanu ^a   Krishnadev, Nupura ^a   Nussenblatt, Robert B ^a   Sen, H Nida ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Avascular necrosis; Corticosteroid; Osteonecrosis; Prednisone; Uveitis

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; AVASCULAR NECROSIS; CALCULATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGAN SYNDROME; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIP PAIN; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; INTERMEDIATE UVEITIS; IRIDOCYCLITIS; KNEE PAIN; LIVEDO RETICULARIS; MALE; MEDICAL RECORD REVIEW; PREVALENCE; RAYNAUD PHENOMENON; RETINA VASCULITIS; RETROSPECTIVE STUDY; RISK FACTOR; SARCOIDOSIS; SICKLE CELL TRAIT; SYMPATHETIC OPHTHALMIA; SYSTEMIC THERAPY; THALASSEMIA; TREATMENT DURATION; UVEITIS; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEONECROSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; UVEITIS; YOUNG ADULT;

EID: 84875969506     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2012.740129     Document Type: Article

References (12)

1. Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32:94-124
2. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000;130:492-513
3. Chang HK, Choi YJ, Baek SK, et al. Osteonecrosis and bone infarction in association with Behçet's disease: Report of two cases. Clin Exp Rheumatol. 2001;19:S51-S54
4. Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715-2724
5. Shigemura T, Nakamura J, Kishida S, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: Prospective MRI study. Rheumatology (Oxford). 2011;50:2023-2028
6. Marston SB, Gillingham K, Bailey RF, et al. Osteonecrosis of the femoral head after solid organ transplantation: A prospective study. J Bone Joint Surg Am. 2002;84-A:2145-2151
7. Sakaguchi M, Tanaka T, Fukushima W, et al. Idiopathic ONF Multicenter Case-control Study Group. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: A nationwide multicenter case-control study in Japan. J Orthop Sci. 2010;15:185-191
8. Nagasawa K, Tada Y, Koarada S, et al. Very early development of steroid-Associated osteonecrosis of femoral head in systemic lupus erythematosus: Prospective study by MRI. Lupus. 2005;14:385-390
9. Oinuma K, Harada Y, Nawata Y, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis. 2001;60:1145-1148
10. Nakamura J, Ohtori S, Sakamoto M, et al. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-Term corticosteroid therapy after disease recurrence. Clin Exp Rheumatol. 2010; 28:13-18
11. Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, et al. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: A prospective study by magnetic resonance imaging. Arthritis Rheum. 2003;48:732-736
12. Nakamura J, Harada Y, Oinuma K, et al. Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI. Lupus. 2010;19: 1307-1314